copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
UCB - Inspired by Patients. Driven by Science. At UCB, we believe that everyone deserves to live the best life that they can That’s why - as a global biopharmaceutical leader - we’re focused on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
UCB in the U. S. | UCB UCB is a global biopharma company focused on creating value for people living with severe diseases Learn more about how UCB delivers value for patients through its patient assistance program, treatment tracker and more
UCB (company) - Wikipedia UCB was founded on 18 January 1928 by Emmanuel Janssen, a Belgian businessman Initially focused on industrial chemicals (it was one of the first companies to distill ammonia from coal), the company also included a small pharmaceutical division based around Meurice Laboratories
Medicines | UCB UCB's medicines are making a real difference to the lives of people all over the world Some of our products are among the leaders in their field For patients: if you wish to report an adverse event related to one of our products, please contact your healthcare provider
About UCB in the United States | UCB We incorporate the individual experiences of patients and caregivers into the discovery, development, and delivery of our medicines, leveraging their insights to inform our science and develop innovative and differentiated solutions
Our Company | UCB UK UCB is a global biopharmaceutical company headquartered in Belgium We employ around 10% of UCB's global workforce - equating more than 1,100 people - in the UK and Ireland in either national, regional or global roles
Diseases - UCB UCB has a deep heritage in neurology, providing a range of solutions for people living with neurological disorders, including epilepsy and Parkinson’s disease
Products | UCB Briviact®, Cimzia®, FINTEPLA®, Keppra XR®, Keppra®, Nayzilam®, Neupro® , RYSTIGGO® and ZILBRYSQ® are registered trademarks of the UCB Group of Companies